Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Ram’s appointment follows the launch of the CDI India division in October 2021.
The division is expected to grow to over a 100-member strong team by 2022
It has planned an investment of over Rs 80 crore in the next five years
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
InferVision's AI applications have been developed to quickly and accurately analyse signs of pulmonary infections from regular chest CT images. These images are processed to indicate ground-glass opacity and high tissue density, which are key findings of viral pneumonia caused by the coronavirus
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
Subscribe To Our Newsletter & Stay Updated
